Treatment of cervical dystonia: A comparison of measures for outcome assessment
Identifieur interne : 004E81 ( Main/Exploration ); précédent : 004E80; suivant : 004E82Treatment of cervical dystonia: A comparison of measures for outcome assessment
Auteurs : Robert Lindeboom [Pays-Bas] ; Jeroen W. M. Brans [Pays-Bas] ; Majid Aramideh [Pays-Bas] ; Hans D. Speelman [Pays-Bas] ; Rob J. De Haan [Pays-Bas]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-07.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Adulte.
English descriptors
- KwdEn :
- Adult, Aged, Botulinum Toxins, Type A (administration & dosage), Botulinum toxins, Botulism, Cervical dystonia, Comparative study, Disability Evaluation, Dystonia, Dystonia Musculorum Deformans (diagnosis), Dystonia Musculorum Deformans (drug therapy), Dystonia Musculorum Deformans (etiology), Evaluation scale, Evolution, Female, Humans, Injections, Intramuscular, Intramuscular administration, Male, Middle Aged, Muscle relaxant, Neck, Neurologic Examination (statistics & numerical data), Neuromuscular Agents (administration & dosage), Outcome assessment, Pain, Pain Measurement (statistics & numerical data), Performance evaluation, Quality of Life, ROC Curve, ROC curve, Size effect, Torticollis (diagnosis), Torticollis (drug therapy), Torticollis (etiology), Toxin, Treatment, Treatment Outcome, Treatment efficiency.
- MESH :
- chemical , administration & dosage : Botulinum Toxins, Type A, Neuromuscular Agents.
- diagnosis : Dystonia Musculorum Deformans, Torticollis.
- drug therapy : Dystonia Musculorum Deformans, Torticollis.
- etiology : Dystonia Musculorum Deformans, Torticollis.
- statistics & numerical data : Neurologic Examination, Pain Measurement.
- Adult, Aged, Disability Evaluation, Female, Humans, Injections, Intramuscular, Male, Middle Aged, Quality of Life, ROC Curve, Treatment Outcome.
Abstract
There is little agreement on which outcome measures to use to express the efficacy of treatments for cervical dystonia. We analyzed change scores on various scales of 64 new patients with cervical dystonia before and after repeated injections with botulinum toxin. Method: The association between change in impairment (Tsui), and change in pain (TWSTRS‐Pain) and functional health (TWSTRS‐D, MOS‐20) was expressed in percentages of variance explained. Effect sizes of the outcome measures from patients who continued botulinum treatment and dropouts were compared. Performance of outcome measures to distinguish patients who continued treatment and dropouts was analyzed with ROC curves and areas under the curve (AUC). Results: Impairments explained ≤ 7% of the score variance in functional health. There were no differences between the effect sizes of impairment and pain of patients who continued treatment and dropouts (p > 0.60). This suggests a poor reflection of the treatment efficacy by these outcome measures. Conversely, there were significant differences between the effect sizes of the functional status scales of the patients who continued treatment and the dropouts (p ≤ 0.01). ROC curve analysis showed that the disability, handicap, and global disease burden scale accurately distinguished between the two groups (AUCs > 0.80). Impairments showed no discriminative accuracy (AUC = 0.46). Conclusion: Neurologic impairments have a small impact on the functional health of cervical dystonia patients. Disability, handicap, and a global measure of disease burden were the most suitable outcome parameters to express the clinical efficacy of botulinum therapy.
Url:
DOI: 10.1002/mds.870130417
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000D84
- to stream Istex, to step Curation: 000D84
- to stream Istex, to step Checkpoint: 003616
- to stream PubMed, to step Corpus: 004371
- to stream PubMed, to step Curation: 004371
- to stream PubMed, to step Checkpoint: 004312
- to stream Ncbi, to step Merge: 005012
- to stream Ncbi, to step Curation: 005012
- to stream Ncbi, to step Checkpoint: 005012
- to stream Main, to step Merge: 007D93
- to stream PascalFrancis, to step Corpus: 002F74
- to stream PascalFrancis, to step Curation: 003850
- to stream PascalFrancis, to step Checkpoint: 002F05
- to stream Main, to step Merge: 008029
- to stream Main, to step Curation: 004E81
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of cervical dystonia: A comparison of measures for outcome assessment</title>
<author><name sortKey="Lindeboom, Robert" sort="Lindeboom, Robert" uniqKey="Lindeboom R" first="Robert" last="Lindeboom">Robert Lindeboom</name>
</author>
<author><name sortKey="Brans, Jeroen W M" sort="Brans, Jeroen W M" uniqKey="Brans J" first="Jeroen W. M." last="Brans">Jeroen W. M. Brans</name>
</author>
<author><name sortKey="Aramideh, Majid" sort="Aramideh, Majid" uniqKey="Aramideh M" first="Majid" last="Aramideh">Majid Aramideh</name>
</author>
<author><name sortKey="Speelman, Hans D" sort="Speelman, Hans D" uniqKey="Speelman H" first="Hans D." last="Speelman">Hans D. Speelman</name>
</author>
<author><name sortKey="De Haan, Rob J" sort="De Haan, Rob J" uniqKey="De Haan R" first="Rob J." last="De Haan">Rob J. De Haan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5EE55952F4B540BD41CA659AE7B55774788DB4BC</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130417</idno>
<idno type="url">https://api.istex.fr/document/5EE55952F4B540BD41CA659AE7B55774788DB4BC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000D84</idno>
<idno type="wicri:Area/Istex/Curation">000D84</idno>
<idno type="wicri:Area/Istex/Checkpoint">003616</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Lindeboom R:treatment:of:cervical</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9686779</idno>
<idno type="wicri:Area/PubMed/Corpus">004371</idno>
<idno type="wicri:Area/PubMed/Curation">004371</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004312</idno>
<idno type="wicri:Area/Ncbi/Merge">005012</idno>
<idno type="wicri:Area/Ncbi/Curation">005012</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005012</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Lindeboom R:treatment:of:cervical</idno>
<idno type="wicri:Area/Main/Merge">007D93</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:98-0353470</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002F74</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003850</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002F05</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Lindeboom R:treatment:of:cervical</idno>
<idno type="wicri:Area/Main/Merge">008029</idno>
<idno type="wicri:Area/Main/Curation">004E81</idno>
<idno type="wicri:Area/Main/Exploration">004E81</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of cervical dystonia: A comparison of measures for outcome assessment</title>
<author><name sortKey="Lindeboom, Robert" sort="Lindeboom, Robert" uniqKey="Lindeboom R" first="Robert" last="Lindeboom">Robert Lindeboom</name>
<affiliation wicri:level="1"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Departments of Neurology, University of Amsterdam</wicri:regionArea>
<wicri:noRegion>University of Amsterdam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brans, Jeroen W M" sort="Brans, Jeroen W M" uniqKey="Brans J" first="Jeroen W. M." last="Brans">Jeroen W. M. Brans</name>
<affiliation wicri:level="1"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Departments of Neurology, University of Amsterdam</wicri:regionArea>
<wicri:noRegion>University of Amsterdam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Aramideh, Majid" sort="Aramideh, Majid" uniqKey="Aramideh M" first="Majid" last="Aramideh">Majid Aramideh</name>
<affiliation wicri:level="1"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Departments of Neurology, University of Amsterdam</wicri:regionArea>
<wicri:noRegion>University of Amsterdam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Speelman, Hans D" sort="Speelman, Hans D" uniqKey="Speelman H" first="Hans D." last="Speelman">Hans D. Speelman</name>
<affiliation wicri:level="1"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Departments of Neurology, University of Amsterdam</wicri:regionArea>
<wicri:noRegion>University of Amsterdam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Haan, Rob J" sort="De Haan, Rob J" uniqKey="De Haan R" first="Rob J." last="De Haan">Rob J. De Haan</name>
<affiliation wicri:level="1"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Clinical Epidemiology and Biostatistics of the Academic Medical Center, University of Amsterdam</wicri:regionArea>
<wicri:noRegion>University of Amsterdam</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-07">1998-07</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="706">706</biblScope>
<biblScope unit="page" to="712">712</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">5EE55952F4B540BD41CA659AE7B55774788DB4BC</idno>
<idno type="DOI">10.1002/mds.870130417</idno>
<idno type="ArticleID">MDS870130417</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Botulinum Toxins, Type A (administration & dosage)</term>
<term>Botulinum toxins</term>
<term>Botulism</term>
<term>Cervical dystonia</term>
<term>Comparative study</term>
<term>Disability Evaluation</term>
<term>Dystonia</term>
<term>Dystonia Musculorum Deformans (diagnosis)</term>
<term>Dystonia Musculorum Deformans (drug therapy)</term>
<term>Dystonia Musculorum Deformans (etiology)</term>
<term>Evaluation scale</term>
<term>Evolution</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Intramuscular administration</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Muscle relaxant</term>
<term>Neck</term>
<term>Neurologic Examination (statistics & numerical data)</term>
<term>Neuromuscular Agents (administration & dosage)</term>
<term>Outcome assessment</term>
<term>Pain</term>
<term>Pain Measurement (statistics & numerical data)</term>
<term>Performance evaluation</term>
<term>Quality of Life</term>
<term>ROC Curve</term>
<term>ROC curve</term>
<term>Size effect</term>
<term>Torticollis (diagnosis)</term>
<term>Torticollis (drug therapy)</term>
<term>Torticollis (etiology)</term>
<term>Toxin</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
<term>Treatment efficiency</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins, Type A</term>
<term>Neuromuscular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dystonia Musculorum Deformans</term>
<term>Torticollis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonia Musculorum Deformans</term>
<term>Torticollis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dystonia Musculorum Deformans</term>
<term>Torticollis</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Neurologic Examination</term>
<term>Pain Measurement</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Quality of Life</term>
<term>ROC Curve</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term>
<term>Botulisme</term>
<term>Cou</term>
<term>Douleur</term>
<term>Dystonie</term>
<term>Echelle évaluation</term>
<term>Effet dimensionnel</term>
<term>Efficacité traitement</term>
<term>Etude comparative</term>
<term>Evaluation performance</term>
<term>Evolution</term>
<term>Myorésolutif</term>
<term>Toxine</term>
<term>Traitement</term>
<term>Voie intramusculaire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is little agreement on which outcome measures to use to express the efficacy of treatments for cervical dystonia. We analyzed change scores on various scales of 64 new patients with cervical dystonia before and after repeated injections with botulinum toxin. Method: The association between change in impairment (Tsui), and change in pain (TWSTRS‐Pain) and functional health (TWSTRS‐D, MOS‐20) was expressed in percentages of variance explained. Effect sizes of the outcome measures from patients who continued botulinum treatment and dropouts were compared. Performance of outcome measures to distinguish patients who continued treatment and dropouts was analyzed with ROC curves and areas under the curve (AUC). Results: Impairments explained ≤ 7% of the score variance in functional health. There were no differences between the effect sizes of impairment and pain of patients who continued treatment and dropouts (p > 0.60). This suggests a poor reflection of the treatment efficacy by these outcome measures. Conversely, there were significant differences between the effect sizes of the functional status scales of the patients who continued treatment and the dropouts (p ≤ 0.01). ROC curve analysis showed that the disability, handicap, and global disease burden scale accurately distinguished between the two groups (AUCs > 0.80). Impairments showed no discriminative accuracy (AUC = 0.46). Conclusion: Neurologic impairments have a small impact on the functional health of cervical dystonia patients. Disability, handicap, and a global measure of disease burden were the most suitable outcome parameters to express the clinical efficacy of botulinum therapy.</div>
</front>
</TEI>
<affiliations><list><country><li>Pays-Bas</li>
</country>
</list>
<tree><country name="Pays-Bas"><noRegion><name sortKey="Lindeboom, Robert" sort="Lindeboom, Robert" uniqKey="Lindeboom R" first="Robert" last="Lindeboom">Robert Lindeboom</name>
</noRegion>
<name sortKey="Aramideh, Majid" sort="Aramideh, Majid" uniqKey="Aramideh M" first="Majid" last="Aramideh">Majid Aramideh</name>
<name sortKey="Brans, Jeroen W M" sort="Brans, Jeroen W M" uniqKey="Brans J" first="Jeroen W. M." last="Brans">Jeroen W. M. Brans</name>
<name sortKey="De Haan, Rob J" sort="De Haan, Rob J" uniqKey="De Haan R" first="Rob J." last="De Haan">Rob J. De Haan</name>
<name sortKey="Speelman, Hans D" sort="Speelman, Hans D" uniqKey="Speelman H" first="Hans D." last="Speelman">Hans D. Speelman</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E81 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E81 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:5EE55952F4B540BD41CA659AE7B55774788DB4BC |texte= Treatment of cervical dystonia: A comparison of measures for outcome assessment }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |